Skip to main content
Log in

PrEP with 6-monthly testing cost effective for MSM and PWID

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 US dollars

Reference

  • Kazemian P, et al. The Cost-effectiveness of HIV Pre-exposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India. Clinical Infectious Diseases : 28 Mar 2019. Available from: URL: http://doi.org/10.1093/cid/ciz249

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PrEP with 6-monthly testing cost effective for MSM and PWID. PharmacoEcon Outcomes News 826, 22 (2019). https://doi.org/10.1007/s40274-019-5824-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5824-7

Navigation